Ten insiders at Mineralys Therapeutics, Inc. (MLYS) have collectively purchased approximately $43.81 million worth of company stock. The transactions, which occurred on March 31, 2026, involved directors and other key personnel from entities including Capital Healthcare Fund Lp Ra, Capital Management, L.P. Ra, and Capital Nexus Fund Iii, L.P.
These purchases included significant blocks of shares acquired at prices around $23.67 and $24.16 per share. Notably, Peter Kolchinsky and Rajeev M. Shah, both directors, were among the individuals making these substantial investments.
This cluster buying activity, where multiple insiders acquire shares concurrently, is often interpreted as a strong bullish signal regarding the company's future prospects.